1. 5.02.2009Marek Jeżabek & Pawel Olko1 Review of research activities 2007-2008 Future Plans

2. 5.02.2009Marek Jeżabek & Pawel Olko2 Outline Particle Physics and Astrophysics Theoretical Physics Nuclear Physics & Strong Interactions Condensed Matter & Material Science Technical Sections NCRH –CCB project (protontherapy at IFJ PAN)

3. 5.02.2009Marek Jeżabek & Pawel Olko3 Polish Particle Physics Roadmap 2011-2016

4. 5.02.2009Marek Jeżabek & Pawel Olko4 Particle Physics and Astrophysics 1. Cosmic Ray Research Pierre Auger Observatory Contribution to the construction of new ”AUGER NORD”. 2. Neutrino and Dark Matter Studies T2K at JPARC substantial contribution to the SMRD subdetector, research programme scheduled for many years, ICARUS (CNGS2), work on detector’s commissioning and software, length of running not settled (CNGS beam by 2011) LAGUNA project (FP7-INFRASTRUCTURES-2007-1) work on possible localization in Poland, responsibility for WP4

5. 5.02.2009Marek Jeżabek & Pawel Olko5 Particle Physics and Astrophysics 3. HERA H1 and ZEUS experiments continue ongoing analyses until 2010 (with continuous generous DESY support) 4. Belle group ”New Physics” programme in B decays with τ leptons searches for B decays (FCNC) with b=>s (d). contribution to low noise Si detector readout to design of modularized pipeline readout electronics system

6. 5.02.2009Marek Jeżabek & Pawel Olko6 Particle Physics and Astrophysics 5. ATLAS p-p: physics of τ leptons Pb-Pb: global properties and collective phenomena maintenance of hardware and software built at IFJ extension of ATLAS programme with ”forward”physics (diffraction). 6. LHCb photons in final states maintenance and development of HLT1 and HLT2 trigger and event reconstruction software. ”Super LHC” upgrade: readout electronics, software. 7. ILC FCAL first prototype segment (30 0 ) ready for DESY test beam in 2010. Full (geant4 style) MC simulation. Design with ”ILC – CLIC universality.”

7. 5.02.2009Marek Jeżabek & Pawel Olko7

8. 5.02.2009Marek Jeżabek & Pawel Olko8 RHIC PHOBOS - data analyses scheduled until 2010. - studies of multiparticle correlations, - event-by-event fluctuations of the elliptic flow. CERN: - ALICE - ATLAS FAIR (GSI) - NUSTAR, - Panda SPIRAL2 (GANIL) - PARIS detector COSY - Wasa, Nuclear Physics & Strong Interactions

9. 5.02.2009Marek Jeżabek & Pawel Olko9 RHIC PHOBOS CERN: - ALICE - ATLAS FAIR (GSI) - NUSTAR - Panda, SPIRAL2 (GANIL) - PARIS detector COSY - Wasa, Nuclear Physics & Strong Interactions Collisions of nuclei at relativistic and ultrarelativistic energies experiments Investigation of pp, pA and AA interactions at SPS energies, up to 158 GeV/nucleon from precedent NA49 Preparation for the data taking at the ALICE experiment at LHC Search for quark-gluon plasma and other phenomena at LHC energies Our technical contribution: Installation of the mass storage for the Tier2/Tier3 computing at the GRID Upgrade of the read-out electronics for the ALICE TPC

10. 5.02.2009Marek Jeżabek & Pawel Olko10 a)Detector laboratory for testing scintillator, silicon and diamond detectors; b)Cluster of LaBr3 detectors compatible with the PARIS design; to be installed later in Krakow c)Adaptation of the Recoil Filter Detector (RFD) for SPIRAL2; d)Installation of the new equipment for in-beam experiments on 250 MeV proton cyclotron planned in IFJ PAN. PARIS detecting system -design and construction

11. 5.02.2009Marek Jeżabek & Pawel Olko11 Theoretical Physics Developing methods and tools for quantitative predictions of the Quantum field theory, Monte Carlo methods for experiments in high energy colliders, Hydrodynamic models for multiparticle production at low energy scales. Monte Carlo generators for LHC heavy-ion programme Modelling parton distribution functions in hadrons and photon, saturation effects. Theory of many-body nuclear systems. Theoretical studies of astrophysics: nonlinearities and chaos in gravitation, dark matter in spiral galaxies, turbulent magnetic fields in supernovas, 5d gravitation. Analysing in quantitative way complex systems in biology, finances, climatology and linguistics of natural languages Theoretical modelling of the effects of short VUV pulses.

12. 5.02.2009Marek Jeżabek & Pawel Olko12 Condensed Matter & Material Science Local research infrastructure –IONMED, … Neutron sources –ILL (Grenoble): coordination of consortium ILLPL –ISIS (RAL) Synchrotron radiation –ESRF –HASYLAB / FLASH / XFEL

13. 5.02.2009Marek Jeżabek & Pawel Olko13 Technical Sections Repair and maintenance of LHC accelerator (2009) XFEL (linac DESY) (2009-2012+) WX7 (Greifswald) (2009-2012+) FAIR (Panda experiment) Synchrotron in Kraków Participation in construction and maintenance of research infrastructure and detectors:

14. 5.02.2009Marek Jeżabek & Pawel Olko14 From JET to ITER Participation in Fusion Projects Participation in the Association EURATOM-Poland Inst. of Plasma Physics and Laser Microfusion Development of neutron detection methods, in particular for the D-D and D-T plasma diagnostics - oriented for the ITER programme - diamond detectors for JET and ITER Collaboration with Max-Planck-Institut für Plasmaphysik Greifswald, Germany - stellarator W-7X 16 engineers and technicians at Greifswald Wendelstein

15. 5.02.2009Marek Jeżabek & Pawel Olko15 Nuclear Energy and Safety Nuclear technology, enviromental monitoring and dosimetry –Strategic Program for Safe Use of Nuclear Energy in Poland –Education in collaboration with AGH UST Thermonuclear energy –Stelarator WX7 (Greifswald) –ITER (neutron transport and cross section measurements)

16. 5.02.2009Marek Jeżabek & Pawel Olko16 Life & Health Reaserch Biomedical research at IFJ PAN: –Van de Graaff accelerator: p microbeam –X-ray microbeam –Isochronous cyclotron AIC-144 –NMR Imaging system –Collaboration with JINR Dubna, DKFZ Heidelberg Strategic Research Project 2008 – 2011, POLISH ARTIFICIAL HEART uncoated TPU TPU + Ti coating formed by IBSD method TPU + (Ti-DLC) coating formed by IBSD method

17. 5.02.2009Marek Jeżabek & Pawel Olko17

18. 5.02.2009Marek Jeżabek & Pawel Olko18 Hadron Radiotherapy at IFJ PAN National Centre for Hadron Radiotherapy (NCRH) –IFJ PAN: AIC-144 protontherapy of eye (2009- 2013) –NCRH – Phase I (IFJ PAN): cycl. 250 MeV (2009+) –NCRH – Phase II (Warsaw): proton & C12 hadron radiotherapy (2010+)

19. 5.02.2009Marek Jeżabek & Pawel Olko19 Consortium National Centre of Hadron Radiotherapy NCRH Grounded: 12.09.2006 IFJ PAN Kraków – coordinator Akademia Górniczo-Hutnicza Medical University, Warszawa, Center of Oncology, Warszawa Center of Oncology, Krakow Holycross Center of Oncology, Kielce Institute of Nuclear Studies (IPJ) Warsaw Polytechnic Silesia University Warsaw University

20. 5.02.2009Marek Jeżabek & Pawel Olko20 NCRH- Phase 1 preliminarily approved -NCRH- CCB is on the list of the projects funded by EU Structural Funds with 25 M€ - Pre-agreement signed with Ministry of Science in Oct. 2007 -The localisation decision for locaction of the new facility obtained in May 2008 - Final project submitted 30.01.2009 - Facility ready 2013

21. 5.02.2009Marek Jeżabek & Pawel Olko21 Outline of the NCRH- Phase 1 facility with the gantry

22. 5.02.2009Marek Jeżabek & Pawel Olko22 Cyclotrons considered IBA -235 MeV cyclotron Accel -250 MeV superconducting cyclotron, power 450 kW

23. 5.02.2009Marek Jeżabek & Pawel Olko23 Cyclotron 225-250 MeV Energy selector Outline of the NCRH- Phase 1 facility Radiobiology lab Eye therapy room Experimental room

24. 5.02.2009Marek Jeżabek & Pawel Olko24 Cyclotron 225-250 MeV Energy selector Experimental room Gantry Patient preparation Radiobiology lab Eye therapy room Outline of the NCRH- Phase 1 facility with the gantry

25. 5.02.2009Marek Jeżabek & Pawel Olko25 Scientific programme of NCRH 1. Radiobiology 2. Nuclear physics 3.Clinical research 4. Dosimetry

26. 5.02.2009Marek Jeżabek & Pawel Olko26 Scientific programme of NCRH 1. Radiobiology 2. Nuclear physics 3.Clinical research 4. Dosimetry RBE issues: 1)Is the RBE for scanning beam equal to RBE for scattered beam? 2)Is for scanning beam the bystander effect observed? 3)Is the RBE higher at the end of Spread Out Bragg peak? 4)Is the clinical RBE for protons = 1.1 suitable for all type of cancers? Scanning beam? 5)Probability of secondary cancer 6)Are the new radiobiological models needed? Groups involved 1.A. Gasinska, D. Słonina Centre of Oncology, Kraków 2.A. Cebulska –Wasilewska, IFJ Kraków 3.M.P.R. Waligórski - modeling

27. 5.02.2009Marek Jeżabek & Pawel Olko27 Scientific programme of NCRH 1. Radiobiology 2. Nuclear physics 3.Clinical research 4. Dosimetry (A,Z) distributions of fission products – structure of the exotic nuclei Method: discrete  -spectroscopy of proton induced (60 – 250 MeV) fission products Goal: a) Production and determination of the structure of the exotic nuclei b) Determination of the of the isotopic distribution of the fission products (transmutation of nuclear waste)

28. 5.02.2009Marek Jeżabek & Pawel Olko28 Scientific programme of NCRH 1. Radiobiology 2. Nuclear physics 3.Clinical research 4. Dosimetry University Children Hospital, Kraków Studies in pediatric oncology - cancers of brain and the Central Nervous System -head and neck Centre of Oncology Kraków -Proton boost Clinic of Ophtalmology Krakow -Ocular melanoma outside the eye globe

29. 5.02.2009Marek Jeżabek & Pawel Olko29 Scientific programme of NCRH 1. Radiobiology 2. Nuclear physics 3.Clinical research 4. Dosimetry Calibration of cosmic –ray detectors for space dosimetry Phantom with TLDs from IFJ 99% of ions in cosmic-rays are protons

30. 5.02.2009Marek Jeżabek & Pawel Olko30 Summary 1.The project National Centre for Hadron Radiotherapy Phase 1 was for final approval 2.230-250 MeV cyclotron will be purchased, new cyclotron bunker and experimental hall will be constructed, eye treatment room will be moved 3.The application for gantry (rotating arm) was submitted 4.The scientific program of the new facility takes into account radiobiology, nuclear physics, clinical research and dosimetry

31. 5.02.2009Marek Jeżabek & Pawel Olko31 Summary and Conclusions  IFJ groups will contribute to major world experiments in particle physics, astrophysics and nuclear physics.  New 250 MeV cyclotron (planned start 2013) will be used for experimental activities (nuclear physics, radiobiology) and radiotherapy of eye melanoma. Gantry will allow for treating pediatric patients.  Biomedical research based on local infrastructure: eye protontherapy, VdG single proton irradiations, MRI, artificial heart  Priorities for safely use of nuclear energy and for fusion projects (ITER, Greifswald)  Income from accredited labs and export of engineers and technicians